345 related articles for article (PubMed ID: 9848697)
21. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
Kaffe S; Hsu LY
Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
[TBL] [Abstract][Full Text] [Related]
22. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
23. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
24. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
25. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
[TBL] [Abstract][Full Text] [Related]
26. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
28. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
Hayashi M; Kohzu H
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels.
Robinson L; Grau P; Crandall BF
Obstet Gynecol; 1989 Jul; 74(1):17-20. PubMed ID: 2471946
[TBL] [Abstract][Full Text] [Related]
30. Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
Lindenbaum RH; Ryynänen M; Holmes-Siedle M; Puhakainen E; Jonasson J; Keenan J
Prenat Diagn; 1987 Sep; 7(7):511-9. PubMed ID: 2444965
[TBL] [Abstract][Full Text] [Related]
31. Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?
Haddow JE; Palomaki GE; Knight GJ
Obstet Gynecol; 1987 Jul; 70(1):26-8. PubMed ID: 2439965
[TBL] [Abstract][Full Text] [Related]
32. Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
Wax JR; Segna RA
J Matern Fetal Med; 1997; 6(6):338-40. PubMed ID: 9438217
[TBL] [Abstract][Full Text] [Related]
33. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS
Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756
[TBL] [Abstract][Full Text] [Related]
34. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
[TBL] [Abstract][Full Text] [Related]
35. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
[TBL] [Abstract][Full Text] [Related]
36. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
37. The impact of MSAFP screening on genetic services, 1984-1986.
Greenberg F
Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
[TBL] [Abstract][Full Text] [Related]
38. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
39. Early pregnancy screening for neural tube defects in Israel.
Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
[TBL] [Abstract][Full Text] [Related]
40. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
